Persistent response of an ovarian cancer patient after a short-term single-agent immunotherapy: a case report

Epithelial ovarian cancer is extremely difficult to treat due to its high recurrence rate and acquired tolerance to chemotherapy. Immune checkpoint inhibitors (ICIs) are expected to be promising solutions for treatment failure. However, the low response rate to a single ICI agent was demonstrated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shaoxing, Sun, Wenjie, Xiang, Qingming, Yang, Chunxu, Chen, Min, Mei, Zijie, Yang, Hui, Zeng, Zihang, Cao, Hong, Tian, Yueli, Zhang, Gong, Qiu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670358/
https://www.ncbi.nlm.nih.gov/pubmed/34338238
http://dx.doi.org/10.1097/CAD.0000000000001178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670358/
https://www.ncbi.nlm.nih.gov/pubmed/34338238
http://dx.doi.org/10.1097/CAD.0000000000001178

Ejemplares similares